JP2018527330A5 - - Google Patents

Download PDF

Info

Publication number
JP2018527330A5
JP2018527330A5 JP2018504650A JP2018504650A JP2018527330A5 JP 2018527330 A5 JP2018527330 A5 JP 2018527330A5 JP 2018504650 A JP2018504650 A JP 2018504650A JP 2018504650 A JP2018504650 A JP 2018504650A JP 2018527330 A5 JP2018527330 A5 JP 2018527330A5
Authority
JP
Japan
Prior art keywords
fibrosis
inhibitor
optionally substituted
alkyl
substituted
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Withdrawn
Application number
JP2018504650A
Other languages
English (en)
Japanese (ja)
Other versions
JP2018527330A (ja
Filing date
Publication date
Application filed filed Critical
Priority claimed from PCT/AU2016/050681 external-priority patent/WO2017015720A1/en
Publication of JP2018527330A publication Critical patent/JP2018527330A/ja
Publication of JP2018527330A5 publication Critical patent/JP2018527330A5/ja
Priority to JP2020127888A priority Critical patent/JP7457360B2/ja
Withdrawn legal-status Critical Current

Links

JP2018504650A 2015-07-30 2016-07-29 線維症の処置 Withdrawn JP2018527330A (ja)

Priority Applications (1)

Application Number Priority Date Filing Date Title
JP2020127888A JP7457360B2 (ja) 2015-07-30 2020-07-29 線維症の処置

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
AU2015903035 2015-07-30
AU2015903035A AU2015903035A0 (en) 2015-07-30 Fibrotic treatment
PCT/AU2016/050681 WO2017015720A1 (en) 2015-07-30 2016-07-29 Fibrotic treatment

Related Child Applications (1)

Application Number Title Priority Date Filing Date
JP2020127888A Division JP7457360B2 (ja) 2015-07-30 2020-07-29 線維症の処置

Publications (2)

Publication Number Publication Date
JP2018527330A JP2018527330A (ja) 2018-09-20
JP2018527330A5 true JP2018527330A5 (cg-RX-API-DMAC10.html) 2019-03-07

Family

ID=57883919

Family Applications (3)

Application Number Title Priority Date Filing Date
JP2018504650A Withdrawn JP2018527330A (ja) 2015-07-30 2016-07-29 線維症の処置
JP2020127888A Active JP7457360B2 (ja) 2015-07-30 2020-07-29 線維症の処置
JP2022199857A Pending JP2023030022A (ja) 2015-07-30 2022-12-15 線維症の処置

Family Applications After (2)

Application Number Title Priority Date Filing Date
JP2020127888A Active JP7457360B2 (ja) 2015-07-30 2020-07-29 線維症の処置
JP2022199857A Pending JP2023030022A (ja) 2015-07-30 2022-12-15 線維症の処置

Country Status (8)

Country Link
US (5) US10100311B2 (cg-RX-API-DMAC10.html)
EP (1) EP3328384B1 (cg-RX-API-DMAC10.html)
JP (3) JP2018527330A (cg-RX-API-DMAC10.html)
AU (1) AU2016301113B2 (cg-RX-API-DMAC10.html)
CA (1) CA3017028C (cg-RX-API-DMAC10.html)
HK (1) HK1256423A1 (cg-RX-API-DMAC10.html)
SG (1) SG11201808478RA (cg-RX-API-DMAC10.html)
WO (1) WO2017015720A1 (cg-RX-API-DMAC10.html)

Families Citing this family (7)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US11306066B2 (en) * 2015-05-08 2022-04-19 Monash University 4H-pyran compounds as insulin-regulated aminopeptidase (IRAP) inhibitors
WO2017015720A1 (en) * 2015-07-30 2017-02-02 Monash University Fibrotic treatment
CN111163793A (zh) * 2017-07-17 2020-05-15 莫纳什大学 血管紧张素受体激动剂及其用途
JP2022516611A (ja) * 2018-12-28 2022-03-01 ザ ジェネラル ホスピタル コーポレイション 線維性疾患の治療のための抗エフリン-b2遮断抗体
WO2021050089A1 (en) * 2019-09-09 2021-03-18 Washington State University Genetic test for identifying cats at a high risk for developing tubulointerstitial fibrosis
TW202143994A (zh) 2020-02-19 2021-12-01 美商希皮恩製藥公司 環孢素類似物於治療纖維化之用途
WO2023099589A1 (en) * 2021-12-01 2023-06-08 INSERM (Institut National de la Santé et de la Recherche Médicale) Irap inhibitors for use in the treatment of inflammatory diseases

Family Cites Families (10)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CA2579768A1 (en) * 2004-09-09 2006-03-16 Howard Florey Institute Of Experimental Physiology And Medicine Enzyme inhibitors and uses thereof
BRPI0615439A2 (pt) * 2005-08-23 2011-05-17 Wyeth Corp métodos para o tratamento de ansiedade e para identificação de agentes ansiolìticos
US8263775B2 (en) * 2007-11-19 2012-09-11 Howard Florey Institute Insulin-regulated aminopeptidase (IRAP) inhibitors and uses thereof
JP2015504870A (ja) * 2011-12-16 2015-02-16 タリックス ファーマシューティカルズ リミテッド 線維症を処置するためのアンジオテンシン
CA2861521A1 (en) * 2012-02-06 2013-08-15 Glaxosmithkline Intellectual Property (No.2) Limited Novel use
JP6327923B2 (ja) 2014-04-25 2018-05-23 旭化成株式会社 ポリアセタール樹脂組成物、及びそれからなる成形体
DE102014114090A1 (de) 2014-09-29 2016-03-31 Karlsruher Institut für Technologie Verfahren zur Abtrennung von Aluminium bei der Calciumsilikatproduktion
US9519061B2 (en) * 2014-12-26 2016-12-13 Here Global B.V. Geometric fingerprinting for localization of a device
US11306066B2 (en) * 2015-05-08 2022-04-19 Monash University 4H-pyran compounds as insulin-regulated aminopeptidase (IRAP) inhibitors
WO2017015720A1 (en) * 2015-07-30 2017-02-02 Monash University Fibrotic treatment

Similar Documents

Publication Publication Date Title
JP2020189845A5 (cg-RX-API-DMAC10.html)
JP6526306B2 (ja) バルドキソロンメチルまたはその類似体を使用して内皮機能障害を処置および予防する方法
Leask et al. Back to the future: targeting the extracellular matrix to treat systemic sclerosis
US20240084308A1 (en) Fibrotic treatment
BR122018015003B1 (pt) kit compreendendo composições farmacêuticas de inibidor da nep e de valsartan ou seus sais
JPWO2005095327A1 (ja) アニリン誘導体
KR20010050798A (ko) 말초 또는 중추 신경계 장애의 치료를 위한 매트릭스금속프로테이나제 억제제인 α-술포닐아미노 히드록삼산
JP2023030022A5 (cg-RX-API-DMAC10.html)
PT1259242E (pt) Utilização de inibidores de tirosina quinase de receptores de pdgf para o tratamento da nefropatia diabética
JP2002544178A (ja) 腎機能障害の治療用の医薬の製造のためのドーパミン−d3−レセプターリガンドの使用
KR20240148350A (ko) 화농성한선염을 치료하기 위한 특정 n-(1-시아노-2-페닐에틸)-1,4-옥사제판-2-카르복스아미드
JP2026069500A (ja) 線維症を治療するためのシクロスポリン類似体の使用
JP7755919B2 (ja) 糖尿病性腎症の予防薬及び/又は治療薬
US20210000798A1 (en) 2,6-DIMETHOXY-4-(5-PHENYL-4-THIOPHENE-2-YL-1H-IMIDAZOL-2-YL)-PHENOL (DPTIP) A SMALL MOLECULE INHIBITOR OF NEUTRAL SPHINGOMYELINASE 2 (nSMase-2) FOR THE TREATMENT OF NEURODEGENERATIVE AND ONCOLOGIC DISEASES
JP2005501015A (ja) アルツハイマー病を治療する方法
TW201215389A (en) Sustained-release therapeutic agent for hypertension and renal dysfunction
JP2008512395A5 (cg-RX-API-DMAC10.html)
KR20240007258A (ko) 리실 옥시다제의 억제제로서 비티아졸 유도체
JP2025511786A (ja) 筋線維症の治療
JP2008528704A5 (cg-RX-API-DMAC10.html)
JPWO2004093858A1 (ja) Mmp発現抑制剤
KR20220140268A (ko) 신규한 인돌라진 유도체 및 이를 포함하는 섬유증의 예방 또는 치료용 조성물
WO2016121862A1 (ja) 抗炎症剤及びその使用
Arts et al. Histone Deacetylase Inhibitors: From Chromatin Remodelling to Experimental Cancer Therapeutics
JP2002326957A (ja) 慢性閉塞性肺疾患の治療方法